Handelsbanken Fonder AB Takes $761,000 Position in National HealthCare Corporation $NHC

Handelsbanken Fonder AB bought a new position in National HealthCare Corporation (NYSEAMERICAN:NHC) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 3,600 shares of the company’s stock, valued at approximately $761,000.

Other hedge funds have also recently made changes to their positions in the company. Royal Bank of Canada increased its position in National HealthCare by 53.6% during the first quarter. Royal Bank of Canada now owns 2,724 shares of the company’s stock valued at $253,000 after acquiring an additional 950 shares during the last quarter. AQR Capital Management LLC grew its position in shares of National HealthCare by 1.7% during the 1st quarter. AQR Capital Management LLC now owns 16,080 shares of the company’s stock valued at $1,492,000 after acquiring an additional 262 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of National HealthCare by 3.1% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,247 shares of the company’s stock worth $858,000 after purchasing an additional 281 shares in the last quarter. Goldman Sachs Group Inc. raised its holdings in National HealthCare by 7.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 73,772 shares of the company’s stock worth $6,846,000 after purchasing an additional 4,879 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in National HealthCare by 18.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 30,246 shares of the company’s stock worth $2,807,000 after purchasing an additional 4,628 shares during the period. 56.44% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the company. The Goldman Sachs Group raised National HealthCare to a “strong-buy” rating in a report on Monday, May 18th. Robert W. Baird raised National HealthCare to a “strong-buy” rating in a research report on Monday, May 18th. Royal Bank Of Canada upgraded National HealthCare to a “hold” rating in a research note on Monday, May 18th. Finally, BMO Capital Markets upgraded shares of National HealthCare to a “hold” rating in a research note on Monday, May 18th. Two analysts have rated the stock with a Strong Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy”.

National HealthCare Stock Performance

NHC stock opened at $234.04 on Thursday. National HealthCare Corporation has a one year low of $109.53 and a one year high of $239.19. The company’s fifty day moving average price is $215.00 and its 200-day moving average price is $186.44. The company has a market capitalization of $3.67 billion, a PE ratio of 26.33 and a beta of 0.61.

National HealthCare (NYSEAMERICAN:NHC) last posted its earnings results on Thursday, August 6th. The company reported $1.74 earnings per share for the quarter. The company had revenue of $408.03 million during the quarter. National HealthCare had a net margin of 9.00% and a return on equity of 10.03%.

National HealthCare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be issued a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a dividend yield of 1.1%. The ex-dividend date of this dividend is Wednesday, September 30th. National HealthCare’s dividend payout ratio is 61.89%.

Insider Buying and Selling at National HealthCare

In other news, Director Lisa Piercey acquired 949 shares of the business’s stock in a transaction dated Monday, June 1st. The stock was purchased at an average price of $184.26 per share, for a total transaction of $174,862.74. Following the completion of the transaction, the director directly owned 949 shares in the company, valued at approximately $174,862.74. This trade represents a ∞ increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 13.92% of the stock is currently owned by insiders.

National HealthCare Profile

National HealthCare Corporation (NYSE American: NHC) is a healthcare services company specializing in long-term care and post-acute rehabilitation. The company operates skilled nursing facilities, assisted living communities and outpatient therapy clinics. Through its subsidiary, National HealthCare Partners, NHC provides contract rehabilitation services, pharmacy management and clinical consulting to a broad network of senior living and healthcare providers.

Headquartered in Murfreesboro, Tennessee, National HealthCare Corporation has built a regional footprint across the southeastern and south-central United States.